Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Glaxo Wellcome

Executive Summary

Glaxo Wellcome: Closing of prescription manufacturing operations in Greenville, N.C. facility is announced July 25 by the company. Prescription manufacturing will be centered in Zebulon, N.C., as Rx operations in Greenville are phased out over the next five years with approximately 1,000 positions to be eliminated. Greenville facility will continue to manufacture over-the-counter products. Glaxo's partially renovated Kenly, N.C. plant is up for sale...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026636

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel